GridAI Technologies (GRDX) Operating Expenses (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Operating Expenses came in at $4.0 million in Q4 2025, up 234.93% YoY from $1.2 million in Q4 2024, and up 331.22% on a QoQ basis from $934787.0 in Q3 2025.
GridAI Technologies (GRDX) Operating Expenses (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Operating Expenses data on file, last reported at $4.0 million in Q4 2025.
- Quarterly Operating Expenses rose 234.93% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (down 58.86% YoY) and the FY2025 annual result came in at $6.4 million, down 58.86% from the prior year.
- Operating Expenses improved to $4.0 million in Q4 2025, from $934787.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $30.4 million in Q3 2021 to a low of -$4.4 million in Q3 2022.
- A 5-year average of $5.5 million and a median of $4.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 718.97% — and 2022, when it sank 114.44%.
- Tracing GRDX's Operating Expenses over 5 years: stood at $11.2 million in 2021, then slumped by 79.59% to $2.3 million in 2022, then soared by 79.57% to $4.1 million in 2023, then sank by 70.6% to $1.2 million in 2024, then soared by 234.93% to $4.0 million in 2025.
- The last three Operating Expenses figures came in at $4.0 million (Q4 2025), $934787.0 (Q3 2025), and $638864.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 934,787.00 |
| Jun 30, 2025 | 638,864.00 |
| Mar 31, 2025 | 821,386.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 9.10 Mn |
| Dec 31, 2023 | 4.09 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | -4.39 Mn |
| Jun 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 9.38 Mn |
| Dec 31, 2021 | 11.17 Mn |
| Sep 30, 2021 | 30.40 Mn |
| Jun 30, 2021 | 9.28 Mn |
| Mar 31, 2021 | 8.21 Mn |